Correction to: First Development, Optimization, and Stability Control of a Pediatric Oral Atenolol Formulation

被引：0
|
作者：
Mauro Morri
Patricia Castellano
Darío Leonardi
Silvana Vignaduzzo
机构：
[1] Universidad Nacional de Rosario,Planta piloto de Producción de Medicamentos, Facultad de Ciencias Bioquímicas y Farmacéuticas
[2] Universidad Nacional de Rosario,Área Análisis de Medicamentos, Departamento Química Orgánica, Facultad de Ciencias Bioquímicas y Farmacéuticas
[3] IQUIR-CONICET,Área Técnica Farmacéutica, Departamento Farmacia, Facultad de Ciencias Bioquímicas y Farmacéuticas
[4] Universidad Nacional de Rosario,Facultad de Ciencias Bioquímicas y Farmacéuticas
[5] Universidad Nacional de Rosario,undefined
来源：
AAPS PharmSciTech | 2018年 / 19卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In the INTRODUCTION section, Atenolol is defined in parenthesis as (ATN, Fig. 1.) The correct definition is (ATN). Fig 1 corresponds to the RESULTS section.
引用
收藏
页码：3907 / 3907
相关论文
共 50 条
  • [1] First Development, Optimization, and Stability Control of a Pediatric Oral Atenolol Formulation
    Morri, Mauro
    Castellano, Patricia
    Leonardi, Dario
    Vignaduzzo, Silvana
    AAPS PHARMSCITECH, 2018, 19 (04): : 1781 - 1788
  • [2] First Development, Optimization, and Stability Control of a Pediatric Oral Atenolol Formulation
    Mauro Morri
    Patricia Castellano
    Darío Leonardi
    Silvana Vignaduzzo
    AAPS PharmSciTech, 2018, 19 : 1781 - 1788
  • [3] First Development, Optimization, and Stability Control of a Pediatric Oral Atenolol Formulation (vol 19, pg 1781, 2018)
    Morri, Mauro
    Castellano, Patricia
    Leonardi, Dario
    Vignaduzzo, Silvana
    AAPS PHARMSCITECH, 2018, 19 (08): : 3907 - 3907
  • [4] Formulation development and optimization: Encapsulated system of atenolol and Glyburide
    Maboos, Madiha
    Yousuf, Rabia Ismail
    Shoaib, Muhammad Harris
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 29 (02) : 569 - 577
  • [5] Formulation, Quality Control and Stability Study of Pediatric Oral Dextrose Gel
    Lamy, Edouard
    Orneto, Caroline
    Ali, Oumil Her Abdou
    Kireche, Lyna
    Mathias, Fanny
    Bouguergour, Cyrielle
    Peyron, Florence
    Primas, Nicolas
    Sauzet, Christophe
    Piccerelle, Philippe
    Maillotte, Anne-Marie
    Brevaut-Malaty, Veronique
    Rathelot, Pascal
    Vanelle, Patrice
    Curti, Christophe
    PHARMACEUTICALS, 2025, 18 (02)
  • [6] Development, validation and stability study of pediatric atenolol syrup
    Foppa, T.
    Murakami, F. S.
    Silva, M. A. S.
    PHARMAZIE, 2007, 62 (07): : 519 - 521
  • [7] Design and stability of pediatric oral formulation of imatinib
    Hinterlang, Melanie
    Gendron, Amandine
    Fleury, Thomas
    Rieutord, Andre
    Vrana, Anastasia
    Schlatter, Joel
    Annereau, Maxime
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (02) : 337 - 342
  • [8] Bridging studies in support of oral pediatric formulation development
    Ricci, Benedicte M.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 457 (01) : 323 - 326
  • [9] Development and Stability Control of Pediatric Oral Tizanidine Hydrochloride Formulations for Hospital Use
    Caren Gobetti
    Maria Eduarda Balsan
    Márcio Vinícius Ayres
    Sílvia Helena Oliveira de Almeida
    Elisa de Saldanha Simon
    Nathalie Ribeiro Wingert
    Tércio Paschke Oppe
    Cássia Virginia Garcia
    AAPS PharmSciTech, 21
  • [10] Development and Stability Control of Pediatric Oral Tizanidine Hydrochloride Formulations for Hospital Use
    Gobetti, Caren
    Balsan, Maria Eduarda
    Ayres, Marcio Vinicius
    Oliveira de Almeida, Silvia Helena
    Simon, Elisa de Saldanha
    Wingert, Nathalie Ribeiro
    Oppe, Tercio Paschke
    Garcia, Cassia Virginia
    AAPS PHARMSCITECH, 2020, 21 (06)
12345